- Earth
Science Tech markets high quality, full-spectrum hemp CBD oil
- The
company’s subsidiaries focus on developing roles as international leaders
in the CBD arena
- ETST
has various partnerships in place to foster product innovation
Earth Science Tech Inc. (OTCQB: ETST) operates in the
fields of hemp cannabinoids, nutraceuticals, pharmaceuticals, medical devices
and research and development. Headquartered in Doral, Florida, the company
offers CBD in the form of vitamins, minerals, herbs, botanicals, personal-care products,
homeopathies, functional foods and other products. An inventive biotech
enterprise, ETST provides high purity and quality full-spectrum hemp CBD oil to
the booming CBD market.
The company’s wholly owned subsidiaries focus on developing
ETST’s role as a global leader in the CBD space. The subsidiaries also focus on
expanding Earth Science Tech’s work in the pharmaceutical and medical device
sectors. Earth Science Tech’s business approach includes promoting its varied
portfolio and pipeline while also engaging in strategic partnerships.
ETST has partnered with the University of Central Oklahoma
and DV Biologics Laboratory to work on projects that scientifically support and
advance the health care benefits of its high-grade hemp CBD oil. Earth Science
Tech’s CBD oil is 100 percent natural and organic and is manufactured using a
supercritical CO2 liquid extraction process.
Earth Science Tech has agreements with CannaBiz and Desert
Sun Distribution (http://ibn.fm/zHKJJ).
These agreements are part of a wider strategy implemented by ETST Chief Sales
Officer David Burbash, who is expanding the sales team to explore product
placement in large chains, health food stores and other establishments. These
agreements are for the distribution of a high-grade, full-spectrum cannabinoids
line throughout pharmacies, chiropractors, dispensaries, athletic clubs and
clinics in the United States.
“We see tremendous synergy between our CBD line and the
health care practitioner and pharmacy spaces,” Burbash stated in a news
release. “The distribution agreements with CannaBiz and Desert Sun
Distribution, while important, are only a fraction of the opportunities we see
for our CBD products.”
ETST’s Earth Science Pharmaceutical Inc. subsidiary is
developing and pioneering medical devices and vaccines to improve women’s
health around the world (http://ibn.fm/OUM9x).
The company is developing low-cost, noninvasive diagnostic tools, medical devices,
testing processes and vaccines for sexually transmitted infections and/or
diseases (STIs). Its first medical device is MSN-2, a home kit designed for the
detection of STIs such as chlamydia from a self-obtained gynecological
specimen. The company is advancing clinical trials of MSN-2 via a collaborative
agreement with Laboratories BNK Canada.
The company’s Cannabis Therapeutics Inc. subsidiary is a
biotech firm focusing on CBD research and development for an extensive line of
cannabinoid-based pharmaceuticals, nutraceuticals and other products and
solutions (http://ibn.fm/26k3p).
The company is working to explore and harness the medicinal power of
cannabidiol. Cannabis Therapeutics has a provisional application patent for
CBD, and its first projects are centered on developing treatments for breast
and ovarian cancers.
Earth Science Tech also has its Canna Inno Laboratories Inc.
subsidiary. The acquisition of Canna Inno provides the company with access to
Government of Canada funding, the first of which has received approval (http://ibn.fm/wkHh2).
Headquartered in Montreal, Canna Inno Laboratories gives Earth Science Tech a
presence in the province of Quebec.
Earth Science Tech continues to advance its product
development in varied dynamic sectors. The company offers investors the potential
for return on investment through its CBD products and international provisional
patent applications. Earth Science Tech is also advancing its vision by
exploring opportunities in new medical frontiers with the unique integration of
CBD with generic drug molecules.
For more information, visit the company’s website at www.EarthScienceTech.com
NOTE TO INVESTORS: The latest news and updates
relating to ETST are available in the company’s newsroom at http://ibn.fm/ETST
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given
situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
